Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 9/20 | 0.53 |
| ▸ | ATM | Q13315 | 2/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 10/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.51 |
| ▸ | MEN1 | O00255 | 7/20 | 0.51 |
| ▸ | POLB | P06746 | 4/20 | 0.51 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 7/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26123368 | 0.86 | MEN1 (0.57) | TDP1ATMNPSR1KMT2AMEN1 | |
| SCHEMBL3768340 | 0.86 | MEN1 (0.57) | TDP1ATMNPSR1KMT2AMEN1 | |
| SCHEMBL26123365 | 0.86 | MEN1 (0.57) | TDP1ATMNPSR1KMT2AMEN1 | |
| SCHEMBL31758256 | 0.84 | TDP1 (0.61) | TDP1ATMNPSR1KMT2AMEN1 | |
| SCHEMBL4808555 | 0.82 | TDP1 (0.56) | TDP1ATMNPSR1KMT2AMEN1 | |
| SCHEMBL4808560 | 0.82 | TDP1 (0.56) | TDP1ATMNPSR1KMT2AMEN1 | |
| SCHEMBL10076051 | 0.82 | TDP1 (0.56) | TDP1ATMNPSR1KMT2AMEN1 | |
| SCHEMBL23341233 | 0.81 | KMT2A (0.48) | TDP1ATMNPSR1KMT2AMEN1 | |
| SCHEMBL28902004 | 0.80 | KLK7 (0.59) | TDP1NPSR1KMT2AMEN1PAX8 | |
| SCHEMBL28902002 | 0.80 | KLK7 (0.59) | TDP1NPSR1KMT2AMEN1PAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260027244-A1 | SILICON-BASED FLUORIDE ACCEPTOR GROUPS FOR RADIOPHARMACEUTICALS | Technische Universität München (DE) | 2026-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027244-A1 | SILICON-BASED FLUORIDE ACCEPTOR GROUPS FOR RADIOPHARMACEUTICALS | SSTR3, SLC43A1, SSTR1 | TDP1 4127/4885ATM 1281/4885NPSR1 1124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.